Professor David Sebag-Montefiore outlines the profound impact of radiotherapy research. Through global trials and personalised approaches, innovation advances cancer care. Collaborative efforts ensure patient-centred treatments, paving the way for smarter, kinder therapies and a future of precision oncology.
Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.
McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
A study released yesterday (28 June) found that it would be safe to mix Pfizer and AstraZeneca doses, which could speed up UK vaccine roll-out if adopted.
